Picture of Kingworld Medicines logo

1110 Kingworld Medicines Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Kingworld Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line70.969.467.693.995.5
Depreciation
Amortisation
Non-Cash Items25.47.049.64-9.89-10.1
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-7.26-30.171.1-61.830.2
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities12481.218742.3136
Capital Expenditures-9.93-58.3-93.5-106-41.1
Purchase of Fixed Assets
Other Investing Cash Flow Items7.177.489.46-15.113.5
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2.76-50.8-84-121-27.6
Financing Cash Flow Items-37.1-13.2-58.2-33.3-60.8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities25-87.2-51.34.37-47.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash137-62.954.2-68.561.6